NEW YORK, April 11 – Biochip maker GeneScan of Freiburg Germany has acquired a minority stake in Oasis Biosciences of San Diego, Reuters reported Wednesday.

GeneScan, which paid $6 million for a “significant” holding in the company, also acquired the option to buy a majority stake in Oasis in one year’s time, Reuters said.

GeneScan acquired the stake in Oasis in order to gain a hold of its technology to improve the speed and reliability of biochips as it prepares to enter the pharmacogenomics sector.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.